Brief: Fresh Tracks Therapeutics Says Board Appointed Deepak Chadha, Co's Chief Research & Development Officer, To Additional Position Of Chief Operating Officer
20/09/2022 21:53
Sept 20 (Reuters) - Fresh Tracks Therapeutics Inc FRTX.O :
* FRESH TRACKS THERAPEUTICS - BOARD APPOINTED DEEPAK CHADHA,
CO'S
CHIEF RESEARCH & DEVELOPMENT OFFICER, TO ADDITIONAL POSITION OF
CHIEF OPERATING OFFICER
* FRESH TRACKS THERAPEUTICS - ANDREW D. SKLAWER, THE
COMPANY’S
PRESIDENT AND CHIEF OPERATING OFFICER, WILL REMAIN THE PRESIDENT
OF THE COMPANY
Further company coverage: FRTX.O
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx